Cell Medica Announces R&D Framework Agreement with the Center for Cell and Gene Therapy at Baylor College of Medicine
1/7/2010 8:54:14 AM
LONDON--(BUSINESS WIRE)--Cell Medica, a clinical cellular therapeutics company developing proven cell therapies which address important unmet clinical needs in oncology and infectious diseases, announced today the signing of an R&D agreement with the Center for Cell and Gene Therapy, a joint program of Baylor College of Medicine, Texas Children’s Hospital and The Methodist Hospital, Houston, Texas. The agreement forms the basis of an extensive collaboration effort aimed at commercializing clinically proven cell therapies which have been pioneered by Baylor and which address human diseases for which no current treatment is available.
comments powered by